In June 2023, UNODC Serbia, with support from the Ministry of Health and international partners, hosted a training in Belgrade on quality assurance for drug use disorder treatment systems. Based on the UNODC-WHO International Standards and...
This Discussion Paper, prepared by UNODC, aligns with key international policy frameworks, including Commission on Narcotic Drugs (CND) resolutions 59/4 and 64/3. These resolutions emphasise the development and dissemination of...
This Discussion Paper, prepared by UNODC, aligns with key international policy frameworks, including CND resolutions 59/4 and 64/3. These resolutions highlight the importance of developing and disseminating international standards for the...
The International Standards for the Treatment of Drug Use Disorders, developed by UNODC and WHO, provide guidance for countries to strengthen evidence-based, ethical and effective treatment systems. They are designed for policymakers...
In 2021, the Commission on Narcotic Drugs (CND) called on UNODC, alongside Member States and partners, to assess the quality of drug prevention, treatment, sustained recovery, and related support services worldwide. This report uses data...
Over 38 million people worldwide are living with drug use disorders, yet only a fraction have access to appropriate treatment. These disorders place a heavy burden on individuals, families and communities, and their wider social costs –...
Improving the quality and coverage of treatment for drug use disorders is a global health priority, highlighted in the United Nations Sustainable Development Goals. To support this, the Key Quality Standards for Drug Use Disorder Treatment...
As a follow-up to our previous webinar outlining the Key Findings of the World Drug Report 2025, ISSUP on 28 August 2025 presented a review of the World Drug Report 2025 through an African lens. The webinar was moderated by Radolf Nortey...
In 1999, the EU highlighted the growing threat of drug abuse and trafficking, noting a sharp rise in cocaine, amphetamines, and synthetic drugs like ecstasy. Reports at the time showed that no Member State was spared from these challenges.
...
